ea0084ps1-03-20 | Thyroid Cancer CLINICAL 1 | ETA2022
Gambale Carla
, Matrone Antonio
, Bottaro Valeria
, Prete Alessandro
, Faranda Alessio
, Contartese Lea
, Bianchi Francesca
, Torregrossa Liborio
, Basolo Fulvio
, Molinaro Eleonora
, Elisei Rossella
Objectives: Currently 131I treatment after surgery is suggested in selected intermediate-risk and in high-risk patients with DTC. In patients with radio-avid structural disease and in those with biochemical disease a second 131I treatment could be considered. However data about the impact of the second 131I treatment on clinical status remains controversial.Methods: Clinical data of 231 DTC patients followed at the Unit o...